Prebiotics and Probiotics for Gastrointestinal Disorders

被引:4
|
作者
Rau, Sameeha [1 ]
Gregg, Andrew [1 ]
Yaceczko, Shelby [1 ]
Limketkai, Berkeley [1 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Vatche & Tamar Manoukian Div Digest Dis, Los Angeles, CA 90095 USA
关键词
prebiotics; probiotics; gut microbiome; dietary supplements; short-chain fatty acids; constipation; diarrhea; irritable bowel syndrome; inflammatory bowel disease; INTESTINAL BACTERIAL OVERGROWTH; ANTIBIOTIC-ASSOCIATED DIARRHEA; GERMINATED BARLEY FOODSTUFF; LACTOBACILLUS-RHAMNOSUS GG; PYLORI ERADICATION THERAPY; RANDOMIZED CLINICAL-TRIAL; DOUBLE-BLIND; ULCERATIVE-COLITIS; FECAL MICROBIOTA; GUT MICROBIOTA;
D O I
10.3390/nu16060778
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
The complex role of the gut microbiome in the pathogenesis of gastrointestinal (GI) disorders is an emerging area of research, and there is considerable interest in understanding how diet can alter the composition and function of the microbiome. Prebiotics and probiotics have been shown to beneficially modulate the gut microbiome, which underlies their potential for benefit in GI conditions. Formulating specific recommendations for the public regarding these dietary supplements has been difficult due to the significant heterogeneity between strains, doses, and duration of treatment investigated across studies, as well as safety concerns with administering live organisms. This review aims to summarize the existing evidence for the use of prebiotics and probiotics in various GI disorders, paying special attention to strain-specific effects that emerged and any adverse effects noted.
引用
下载
收藏
页数:22
相关论文
共 50 条